Pandemic
Global Health at a Crossroads and the Future of Pandemic Preparedness
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-17Mar 12, 2025
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
David Dodd; Mark Newman, Ph.D.
GeoVax Inc.
PAO-10-23-CL-07Nov 09, 2023
Vaccine and Cell & Gene Therapies
Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics
lrike Fiedler Dr. Rer. Nat.
IDT Biologika
PAO-04-022-CL-02Apr 13, 2022
Column: Technology
mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PAO-03-022-NI-02Mar 23, 2022
COVID-19 Vaccines
Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-022-NI-05Mar 18, 2022
COVID-19 Vaccines
The Global Immunization Disparity
Komal Hatti
IPS-Integrated Project Services, LLC
PAO-02-022-CL-04Mar 12, 2022
COVID-19 Vaccine
AGC Biologics Supports Omicron-Based Vaccine Candidate Manufacturing with Starting Material
AGC Biologics
PR-M02-22-07Feb 09, 2022
COVID-19 Vaccine
FDA Approves SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine
Brand Institute
PR-M02-22-01Feb 01, 2022
Thermal Packaging
With Omicron Variant on the Rise, Thermal Custom Packaging (TCP) is Providing Secure Transportation of COVID Vaccine
Thermal Custom Packaging
PR-M01-22-02Jan 04, 2022
Collaboration
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001
IDT Biologika
PR-M12-21-02Dec 15, 2021
Viral Vaccines
Viral Vectors, Vaccines — A New Era Of Collaborative Design
Andreas Neubert, Ph.D.
IDT Biologika
PAO-10-21-CL-17Nov 08, 2021
Gene Therapy
Pandemic Playbook for Gene Therapy Manufacturing
Ratish Krishnan; David Loong, Ph.D.; Nargisse El-Hajjami, Ph.D.
MilliporeSigma
PAO-09-21-CL-14Sep 29, 2021
COVID-19 Vaccine
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial
Novavax
PR-M06-21-028Jun 22, 2021
Cleanrooms
Rapid Cleanroom Builds for COVID-19 Facilities: Lessons Learned
Grant Merrill; Jose Jimenez
AES Clean Technology Inc.
PAO-06-21-CL-06Jun 18, 2021
Genetic Vaccines
Working to Overcome Analytical Challenges Posed by Genetic Vaccines
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-21-NI-01Jun 04, 2021
COVID-19
Preparing for the Next Pandemic: Lessons Learned from COVID-19
Sheila Rocchio
eClinical Solutions
PAO-06-21-CL-01Jun 01, 2021
COVID-19 Vaccine
Pfizer and BioNTech to Vaccinate Olympic Athletes in Tokyo
Pfizer
PR-M05-21-014May 20, 2021
COVID-19 Vaccine
Sanofi and GSK COVID-19 Vaccine Candidate Demonstrates Strong Immune Responses Across All Adult Age Groups in Phase 2 Trial
Sanofi
PR-M05-21-011May 17, 2021
Vaccines
A Look at Genetic Vaccine Development and Manufacturing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-21-NI-03May 17, 2021
COVID-19 Vaccines
The COVID-19 Vaccine Journey Continues
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-21-NI-02May 13, 2021